Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic surgery through the mouth could eliminate neck scars in thyroid cancer patients

NCT ID NCT06958601

Disease control Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This trial compares a new robotic surgery that removes the thyroid through the mouth (transoral vestibular approach) to the standard open surgery with a neck incision. The study includes 430 adults aged 18–65 with papillary thyroid cancer. The goal is to see if the robotic method is as safe and effective as open surgery, while offering better cosmetic results and shorter hospital stays. The robotic approach is being tested mainly for tumors smaller than 2 cm.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transoral robotic thyroidectomy (surgical procedure)
What this could lead to
If successful, this approach could offer a safe, scarless alternative to traditional open thyroidectomy for small thyroid cancers, reducing hospital stays and improving cosmetic results.
What could go wrong
This is a single-center trial, and the robotic method may not be suitable for tumors larger than 2 cm. As with any surgery, risks include nerve damage, bleeding, and infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

430 people

The number who actually took part.

Started

May 2025

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Thyroid cancer patients

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18- 65 years old, both male and female * Postoperative pathology was papillary thyroid carcinoma * Clinical data integrity Exclusion Criteria: * Postoperative pathology was benign * Clinical data are incomplete

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Papillary thyroid carcinoma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thyroid cancer thyroid gland papillary carcinoma Thyroid Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Thyroid cancers

Contacts and locations

Locations

  • Daping Hospital

    Chongqing, Chongqing Municipality, 400042, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.